Tectonic Therapeutic | AVRO - Selling And Administration Expenses


Tectonic Therapeutic reported $6.17M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alnylam Pharmaceuticals USD 342M 5.92M Sep/2026
Celltrion KRW 12.72B 3.4B Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.52B 70M Jun/2026
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Karyopharm Therapeutics USD 10.42M 861K Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
MacroGenics USD 7.9M 1.81M Jun/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organigram Holdings CAD 26.51M 4.5M Jun/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pfizer USD 3.28B 132M Sep/2026
Pharma Mar EUR 15.53M 1.59M Sep/2026
Qiagen NV USD 142.33M 60K Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sanofi EUR 2.31B 325M Sep/2026
Sarepta Therapeutics USD 118.61M 11.01M Sep/2026
Sartorius EUR 216.6M 4.7M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Takeda JPY 271.71B 14.8B Sep/2026
Tilray USD 24.85M 1.7M Sep/2025
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026